However, MRTF-A deficiency in macrophages reverses the above transcription process, resulting in alleviating inflammatory response and cardiac hypertrophy (68), thereby indicating that suppression of the interaction between macrophages and endothelial cells to attenuate the inflammatory response is a novel therapeutic idea for HF (Figure 2). This evidence concerns the gene MRTFA and cardiac hypertrophy.